Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Stomach Neoplasms 2Vomiting 1Squamous Cell Carcinoma of Head and Neck 1Postoperative Nausea and Vomiting 1Multiple Myeloma 1Lymphoma 1Carcinoma 1Breast Carcinoma In Situ 1Adenocarcinoma, Mucinous 1

Interventions

atezolizumab 2irinotecan sucrosofate 1cobimetinib 1Paclitaxel 1Oxaliplatin 1Nivolumab 1Leucovorin 1Immunoglobulin G 1Fluorouracil 1Famotidine 1Disulfides 1Diphenhydramine 1Dexamethasone 1DNA Fingerprinting 1Chemoradiotherapy 1Calcium Dobesilate 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma, Mucinous × Famotidine × Clear all
NCT06207305 2026-01-13

A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
39 enrolled

Adenocarcinoma, Mucinous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡